AXA Venture Partners

AXA Venture Partners (AVP) is a venture capital fund investing in high-growth, technology-enabled companies. AVP has built a unique investment platform specialized in tech investments with $600 million of assets under management through three pillars of investment expertise: Early Stage Fund, Growth Stage Fund and Fund of Funds. To date, AVP has invested in 40 Early and Growth equity deals and 6 Fund investments. AVP team operates globally backed by offices in San Francisco, New York, London, Paris and Hong Kong. Beyond investments, AVP provides access to business development opportunities helping portfolio companies to scale globally and accelerate their growth.

AXA Venture Partners, established in 2015 and headquartered in Europe., specializes in Early Stage Venture, Seed, Late Stage Venture, Private Equity investments across Health Care, Medical, Wellness, mHealth, Contact Management, Messaging, CRM, Financial Services, Finance, FinTech. The organization boasts a portfolio of 114 investments, with an average round size of $28.2M and 16 successful exits. Their recent investments include Mindoula Health, Kwaga, Policygenius, MassMutual Ventures, Susa Ventures. The highest investment round they participated in was $263.8B. Among their most notable exits are Mindoula Health and Kwaga. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.